Start-Up Acceleration

Covar gladly assists early-stage start-ups in drug candidate selection, development cost estimates, and project planning through our Start-Up Molecule Acceleration program.

It cannot be overstated how essential appropriate drug candidate selection and the first few development decisions are to the survival or collapse of a biopharmaceutical start-up. Development expertise (including CMC) should be integrated as early as possible with founders, investors, and researchers to avoid the costly mistakes and delays that are often caused by incomplete information.

Our Start-Up Molecule Acceleration program is intended to be priced attractively and may include:

• Product development roadmap for early development, CMC, animal & human studies, and scale up for your molecule.

• Developability cost estimates & risk profile, considering intended dosage form, mechanism of action, drug toxicology, and biopharmaceutical profile.

All offerings are customized to your start-up’s technology pipeline and are intended to assist start-ups with development planning and fund raising.